Here's why the CNBC host isn't ready to embrace IonQ, despite its place in one of Wall Street's hottest emerging technology ...
U.S. stocks have minted a fortune for investors, with the benchmark S&P 500 returning nearly 70% over the past five years.
Healthcare giant Johnson & Johnson (NYSE:JNJ) is one of Jim Cramer’s top healthcare stocks even though the shares have been lackluster. They are up by a modest 27% year-to-date, with most of the gains ...
CNBC's Jim Cramer urged investors not to overreact to earnings season volatility, saying short-term market moves often defy ...
Bill McDermott, ServiceNow chairman and CEO, joins 'Mad Money' host Jim Cramer to recap the company's quarterly results, ...
Jim Cramer’s most durable investing rule is a short one: some stocks you own, and some stocks you trade. For years he has ...
'Mad Money' host Jim Cramer weighs in on stocks including: Figma, Solaredge, IONQ, Independent Bank Corp, and Constellation ...
Jim Cramer believes forced selling is creating opportunities, but investors should resist buying too early. During his July ...
How dangerous is it when homegrown companies integrate technology from China in the battle for AI dominance?
Famed investor Jim Cramer has declared Intel INTC a “miracle stock” ahead of the giant’s fiscal Q2 earnings set to be ...
Jim Cramer highlights a hedge fund's stake in ex-Bitcoin miner Keel Infrastructure as it pivots to AI data centers.
Netflix stock is down 40% over the past year and fell again after earnings. Jim Cramer says the selloff went too far and lays out how to buy it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results